ACADIA Pharmaceuticals Inc. (ACAD)
NASDAQ: ACAD · Real-Time Price · USD
24.97
+0.38 (1.55%)
At close: Feb 25, 2026, 4:00 PM EST
25.32
+0.35 (1.40%)
After-hours: Feb 25, 2026, 6:44 PM EST
ACADIA Pharmaceuticals Stock Forecast
Stock Price Forecast
The 23 analysts that cover ACADIA Pharmaceuticals stock have a consensus rating of "Buy" and an average price target of $30.35, which forecasts a 21.55% increase in the stock price over the next year. The lowest target is $17 and the highest is $40.
Price Target: $30.35 (+21.55%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for ACADIA Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 6 | 6 | 7 | 7 | 7 |
| Buy | 8 | 8 | 8 | 8 | 8 | 10 |
| Hold | 7 | 6 | 6 | 7 | 6 | 5 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 21 | 21 | 21 | 23 | 22 | 23 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wolfe Research | Wolfe Research | Buy Initiates $33 | Buy | Initiates | $33 | +32.16% | Feb 24, 2026 |
| Mizuho | Mizuho | Hold → Buy Upgrades $29 → $35 | Hold → Buy | Upgrades | $29 → $35 | +40.17% | Feb 23, 2026 |
| Oppenheimer | Oppenheimer | Hold Maintains $21 → $23 | Hold | Maintains | $21 → $23 | -7.89% | Feb 6, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $35 → $31 | Buy | Maintains | $35 → $31 | +24.15% | Feb 3, 2026 |
| Citizens | Citizens | Buy Reiterates $34 | Buy | Reiterates | $34 | +36.16% | Feb 3, 2026 |
Financial Forecast
Revenue This Year
1.10B
from 957.80M
Increased by 15.06%
Revenue Next Year
1.23B
from 1.10B
Increased by 11.34%
EPS This Year
0.82
from 1.36
Decreased by -39.99%
EPS Next Year
0.77
from 0.82
Decreased by -6.27%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 1.1B | 1.3B | ||||
| Avg | 1.1B | 1.2B | ||||
| Low | 1.1B | 1.1B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 19.3% | 19.5% | ||||
| Avg | 15.1% | 11.3% | ||||
| Low | 9.7% | 3.0% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 0.97 | 1.25 | ||||
| Avg | 0.82 | 0.77 | ||||
| Low | 0.54 | 0.35 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -29.0% | 53.1% | ||||
| Avg | -40.0% | -6.3% | ||||
| Low | -60.4% | -56.8% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.